These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8981056

  • 1. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation.
    Vanden Heuvel JP.
    Gen Pharmacol; 1996 Oct; 27(7):1123-9. PubMed ID: 8981056
    [Abstract] [Full Text] [Related]

  • 2. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.
    Vanden Heuvel JP, Sterchele PF, Nesbit DJ, Peterson RE.
    Biochim Biophys Acta; 1993 Jun 06; 1177(2):183-90. PubMed ID: 8499488
    [Abstract] [Full Text] [Related]

  • 3. Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats.
    Kim SC, Hong JT, Jang SJ, Kang WS, Yoo HS, Yun YP.
    J Toxicol Sci; 1998 May 06; 23(2):113-9. PubMed ID: 9644651
    [Abstract] [Full Text] [Related]

  • 4. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
    Wilson MW, Lay LT, Chow CK, Tai HH, Robertson LW, Glauert HP.
    Arch Toxicol; 1995 May 06; 69(7):491-7. PubMed ID: 8526745
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
    Chen H, Huang CY, Wilson MW, Lay LT, Robertson LW, Chow CK, Glauert HP.
    Carcinogenesis; 1994 Dec 06; 15(12):2847-50. PubMed ID: 8001245
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of long-chain acyl-CoA synthetase by the peroxisome proliferator perfluorodecanoic acid in rat hepatocytes.
    Vanden Heuvel JP, Kuslikis BI, Shrago E, Peterson RE.
    Biochem Pharmacol; 1991 Jul 05; 42(2):295-302. PubMed ID: 1859447
    [Abstract] [Full Text] [Related]

  • 10. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
    Glauert HP, Srinivasan S, Tatum VL, Chen LC, Saxon DM, Lay LT, Borges T, Baker M, Chen LH, Robertson LW.
    Biochem Pharmacol; 1992 Mar 17; 43(6):1353-9. PubMed ID: 1562286
    [Abstract] [Full Text] [Related]

  • 11. Effect of the peroxisome proliferator perfluorodecanoic acid on growth and lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium.
    Borges T, Glauert HP, Chen LC, Chow CK, Robertson LW.
    Arch Toxicol; 1990 Mar 17; 64(1):26-30. PubMed ID: 2306190
    [Abstract] [Full Text] [Related]

  • 12. Effects of peroxisome proliferators on rat liver phospholipids: sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid.
    Adinehzadeh M, Reo NV.
    Chem Res Toxicol; 1998 May 17; 11(5):428-40. PubMed ID: 9585473
    [Abstract] [Full Text] [Related]

  • 13. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
    Wilson MW, Leung LK, Hong JT, Glauert HP.
    Adv Exp Med Biol; 1997 May 17; 400A():439-45. PubMed ID: 9547588
    [No Abstract] [Full Text] [Related]

  • 14. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
    Glauert HP, Hong JT, Leung LK, Wilson MW.
    Ann N Y Acad Sci; 1996 Dec 27; 804():719-21. PubMed ID: 8993604
    [No Abstract] [Full Text] [Related]

  • 15. Modification of hepatic immunoglobulin heavy chain binding protein (BiP/Grp78) following exposure to structurally diverse peroxisome proliferators.
    Witzmann FA, Jarnot BM, Parker DN, Clack JW.
    Fundam Appl Toxicol; 1994 Jul 27; 23(1):1-8. PubMed ID: 7958552
    [Abstract] [Full Text] [Related]

  • 16. Charge modification in rodent hepatic Grp78/BiP following exposure to structurally diverse peroxisome proliferators.
    Witzmann FA, Jarnot BM, Clack JW.
    Appl Theor Electrophor; 1994 Jul 27; 4(2):81-8. PubMed ID: 7880882
    [Abstract] [Full Text] [Related]

  • 17. Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
    Cai Y, Appelkvist EL, DePierre JW.
    J Biochem Toxicol; 1995 Apr 27; 10(2):87-94. PubMed ID: 7562957
    [Abstract] [Full Text] [Related]

  • 18. Effects of the peroxisome proliferator perfluoro-n-decanoic acid on hepatic gluconeogenesis and glycogenesis: a 13C NMR investigation.
    Goecke CM, Jarnot BM, Reo NV.
    Chem Res Toxicol; 1994 Apr 27; 7(1):15-22. PubMed ID: 8155820
    [Abstract] [Full Text] [Related]

  • 19. PPAR: a mediator of peroxisome proliferator action.
    Green S.
    Mutat Res; 1995 Dec 27; 333(1-2):101-9. PubMed ID: 8538617
    [Abstract] [Full Text] [Related]

  • 20. The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells.
    Boujrad N, Vidic B, Gazouli M, Culty M, Papadopoulos V.
    Endocrinology; 2000 Sep 27; 141(9):3137-48. PubMed ID: 10965884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.